CD4 and neoplasm: Further, within both CD8+ and CD4+ T cells – both within the tumor and spleen – we observed a shift towards Ki67+CD69+ and Ki67+PD-1+ cells, indicating the prevalence of both proliferating and activated lymphocytes in response to AP-diABZI (Fig. 6d,e, Extended Data Fig. 7).